郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.

期刊：Molecular pain发表年份：2014作者：Tanila Ben Haddou; Davide Malfacini; Girolamo Calo; Mario D Aceto; Louis S Harris; John R Traynor; Andrew Coop; Helmut Schmidhammer; Mariana Spetea
阅读更多 →

药效评价SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?

期刊：Thrombosis research发表年份：2014作者：N Delesque-Touchard; A M Pflieger; S Bonnet-Lignon; L Millet; V Salel; C Boldron; G Lassalle; J M Herbert; P Savi; F Bono
阅读更多 →

药效评价Development of a novel triamcinolone acetonide-loaded spray solution for the treatment of stomatitis.

期刊：Die Pharmazie发表年份：2014作者：Dong Wuk Kim; Yong-Il Kim; Fakhar Ud Din; Kwan Hyung Cho; Jong Oh Kim; Han-Gon Choi
阅读更多 →

药效评价A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma.

期刊：International immunopharmacology发表年份：2014作者：E Méndez-Enríquez; J Medina-Tamayo; G Soldevila; T I Fortoul; B Anton; L Flores-Romo; E A García-Zepeda
阅读更多 →